Frequently Asked Questions on the Revocation of the Emergency Use Authorization for Hydroxychloroquine Sulfate and Chloroquine Phosphate | NLM

Disaster Information Management Research Center | NLM

Frequently Asked Questions on the Revocation of the Emergency Use Authorization for Hydroxychloroquine Sulfate and Chloroquine Phosphate

06/15/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/15/2020. This three-page fact provides answers to frequently asked questions about the revocation of the Emergency Use Authorization for hydroxychloroquine sulfate and chloroquine phosphate to treat COVID-19. The Food and Drug Administration has determined that these drugs are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA. (PDF)